Dysfunctional Breathing, Exercise Capacity, and Balance in Hypertension
Relationship Between Dysfunctional Breathing, Exercise Capacity, and Balance in Patients With Hypertension: A Prospective Cross-Sectional Study
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Elif Kabasakal, MSc
- Phone Number: +905347093738
- Email: elif.kabasakal@istinye.edu.tr
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Istınye University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged between 18 and 70 years
- Diagnosed with hypertension and under follow-up for at least 6 months
- Willing to participate in the study voluntarily
- Nijmegen Questionnaire score of 23 or above
Exclusion Criteria:
- Medication change within the last month prior to study enrollment
- Presence of unstable metabolic disease
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Hypertensive Patients With Dysfunctional Breathing
Participants diagnosed with arterial hypertension who exhibit symptoms of dysfunctional breathing, as determined by the Nijmegen Questionnaire.
Assessments will include anthropometric measurements, functional exercise capacity tests, and balance evaluations.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Dysfunctional Breathing Level
Time Frame: At baseline
|
Nijmegen Questionnaire: The questionnaire is used for the assessment and identification of respiratory dysfunction, unexplained respiratory symptoms, and hyperventilation syndrome indicators.
It consists of 16 items covering neurological, cardiovascular, respiratory, gastrointestinal, and psychological factors.
Each item is rated on a 5-point Likert scale, with a total score ranging from 0 to 64.
Higher scores indicate an increased likelihood of respiratory dysfunction and hyperventilation syndrome.
A score above 23 supports the possible diagnosis of dysfunctional breathing.
The questionnaire has a sensitivity of 91% and a specificity of 95%.
The Turkish version of the questionnaire has been validated and found to be reliable.
|
At baseline
|
|
Assessment of Balance-I
Time Frame: At baseline
|
The Timed Up and Go Test is a method used to rapidly assess an individual's balance control.
During the test, the participant is instructed to rise from a seated position in a chair, walk a distance of 3 meters, turn around a reference object, return to the chair, and sit down again.
The time taken to complete the task is recorded in seconds.
The test will be repeated three times, and the average of the three trials will be used for analysis.
|
At baseline
|
|
Assessment of Balance-II
Time Frame: At baseline
|
The Berg Balance Scale is used to assess balance through progressively challenging tasks by reducing the level of support provided by the surface.
The scale consists of 14 items, each scored from 0 to 4 (4: best performance, 0: poorest performance).
A total score between 41-56 indicates a low risk of falling, 21-40 reflects a medium fall risk, and scores below 20 indicate a high fall risk.
|
At baseline
|
|
Neck Circumference Measurements
Time Frame: At baseline
|
Neck circumference will be measured using a flexible plastic measuring tape at the level of the cricoid cartilage, with the participant in an upright and relaxed position
|
At baseline
|
|
Waist Circumference Measurement
Time Frame: At baseline
|
Waist circumference will be measured using a flexible plastic measuring tape at the level of the iliac crest, with the participant standing upright and breathing normally.
|
At baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Kabasakal, Istinye University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ISU-2025-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.